InspireMD, Inc. (NSPR) Institutional Ownership

Ownership Summary

InspireMD, Inc. (NASDAQ:NSPR) has 43 institutional investors that have filed 13F reports for the period ending December 2025.

• They owned 28.2% of outstanding stock in December 2025, down from 30.9% the prior quarter.
• Their total shares held in NSPR increased 9.25% quarter over quarter, and separately, investors owning InspireMD increased 43.33% from a year ago.
• Activity in NSPR broke down as 18 buyers, 5 sellers, and 20 unchanged among 43 total holders.
• The aggregate institutional position in InspireMD amounted to 20.73Mn shares as of December 2025, up by 1.75Mn shares quarter on quarter, and up 5.41Mn shares year over year.
• Rosalind Advisors, Inc. leads ownership in NSPR with 3.91Mn shares as of December 31, 2025, equal to 5.32% of outstanding shares.
• Leading buyers of InspireMD shares for the quarter ending December 2025 were ORBIMED ADVISORS LLC (1.0Mn), Aberdeen Group plc (692.25K), INGALLS & SNYDER LLC (159.3K), CITADEL ADVISORS LLC (155.76K), ESSEX INVESTMENT MANAGEMENT CO LLC (114.08K).
• The biggest sellers of InspireMD for the quarter ending December 2025 included Soleus Capital Management, L.P. (320.93K), Schonfeld Strategic Advisors LLC (62.76K), Morgan Stanley (44.18K), MILLENNIUM MANAGEMENT LLC (23.33K), Bank Of America Corp /De/ (1.1K).
• InspireMD's 10 largest shareholders as of December 2025 include Rosalind Advisors, Inc. (3.91Mn), Nantahala Capital Management, LLC (3.38Mn), Aberdeen Group plc (3.17Mn), ORBIMED ADVISORS LLC (3.13Mn), Velan Capital Investment Management LP (2.14Mn), MARSHALL WACE, LLP (1.86Mn), Soleus Capital Management, L.P. (1.15Mn), PURA VIDA INVESTMENTS, LLC (450.52K), INGALLS & SNYDER LLC (384.3K), Affiance Financial, LLC (250.37K) per Business Quant data.